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ABSTRACT Amyloid ﬁbrils are associated with more than 20 diseases, including Alzheimer’s disease and type II diabetes.
Insulin is a 51-residue polypeptide hormone, with its two polypeptide chains linked by one intrachain and two interchain disulﬁde
bonds, and has long been known to self-assemble in vitro into amyloid ﬁbrils. We demonstrate here that bovine insulin forms
ﬂexible ﬁlaments in the presence of a reducing agent, Tris (2-carboxyethyl) phosphine. The insulin ﬁlaments, possibly formed
due to partial reduction of S-S bonds in insulin molecules, differ from intact insulin ﬁbrils in terms of their secondary structure.
The insulin ﬁlaments were determined to have an antiparallel b-sheet structure, whereas the insulin ﬁbrils have a parallel b-sheet
structure. Of importance, the cell toxicity of the insulin ﬁlaments was remarkably lower than that of the insulin ﬁbrils. This ﬁnding
supports the idea that cell toxicity of amyloids correlates with their morphology. The remarkably low toxicity of the ﬁlamentous
structure should shed new light on possible pharmacological approaches to the various diseases caused by amyloid ﬁbrils.doi: 10.1016/j.bpj.2008.12.3957INTRODUCTION
Protein aggregation, and amyloid formation in particular, are
receiving considerable interest because growing evidence
indicates that they are likely to be key issues in the etiology
of more than 20 disease states, including Alzheimer’s
disease, Parkinson’s disease, and Creutzfeldt-Jakob disease
(1–3). Recent studies have shown that a number of nondi-
sease-associated proteins can also form similar amyloid-
like fibers under appropriate conditions in vitro, suggesting
that such conformations are common to many proteins (1,3).
Although no sequence or structural similarity between the
amyloid precursor proteins has been found, amyloid fibrils
share several common structural and spectroscopic proper-
ties. Amyloid fibrils are typically rigid, unbranched struc-
tures with diameters of 8–13 nm and lengths of up to several
micrometers. They are typified by a cross-b structure in
which the b-strands are aligned perpendicularly to the long
axis of the fibril (4), and by characteristic spectroscopic
properties when dyes such as thioflavine T (ThT) and Congo
red (CR) bind (5).
One of the most intensively studied amyloid-forming
proteins is insulin. Insulin, a 51-residue polypeptide
hormone, has a mainly helical native structure, with its
two polypeptide chains linked by one intrachain and two
interchain disulfide bonds (6). Amyloid deposits of insulin
molecules were previously observed in a patient with
insulin-dependent diabetes undergoing treatment by injec-
tion of porcine insulin (7). In vitro, insulin is readily
converted to an inactive b-sheet-rich amyloid fibrillar form
by incubation at high insulin concentrations, acidic pH,
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solvents and agitation (8). It has been proposed that insulin
fibrillation occurs through the dissociation of oligomers
into monomers, with the monomer undergoing structural
changes to partially folded intermediates that have a strong
propensity to fibrillate (9–11).
The structure of insulin is substantially constrained by two
disulfide bridges that cross-link the A-chain and B-chain,
and a third disulfide bridge within the A-chain, all of which
are retained in the fibrillar state (8). Devlin et al. (12) and
Hong and Fink (13) showed that both the A-chain and
B-chain of bovine insulin can independently form amyloid
fibrils under conditions similar to those for the intact insulin.
A detailed atomic force microscopy study showed that the
fibrils of the A-chain and B-chain were different from the
intact insulin fibrils in terms of diameter, helical repeat,
and twist properties (12), which suggests that disulfide
bonds cross-linking the A-chain and B-chain affect insulin
fibrillation.
In this study, we examine the effect of reduction of the
disulfide bonds on bovine insulin fibrillation. Since bovine
insulin was dissolved and fibrillated in an acidic buffer,
we used the reducing agent Tris(2-carboxyethyl)phosphine
(TCEP), which works under acidic conditions (14). We
demonstrate that in the presence of TCEP, insulin forms flex-
ible filaments that are morphologically much different from
typical insulin fibrils. Furthermore, we show that insulin fila-
ments differ from insulin fibrils in terms of secondary struc-
ture and cell toxicity. This implies that the cell toxicity of
amyloid fibrils is closely connected with their morphology.
Since this filamentous aggregate could not be formed from
the A-chains and B-chains independently, or from their
mixture, we suggest that filament formation may be induced
by a partial reduction of the disulfide bonds of insulin.
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Materials
Bovine insulin and oxidized bovine insulin A-chains and B-chains were
purchased from Sigma-Aldrich (St. Louis, MO). The cysteine residues of
oxidized bovine insulin A-chains and B-chains were oxidized to cysteine-
sulfonic acid (Cys-SO3H). ThT and CR were also obtained from Sigma-
Aldrich. TCEP was obtained from Pierce (Rockford, IL). All other reagents
were of analytical grade. Aqueous solutions were prepared with deionized
Milli-Q water (Millipore, Billerica, MA) throughout this study.
Preparation of insulin samples
All protein samples were prepared immediately before the experiments were
performed. Insulin was dissolved at a concentration of 20 mg/mL in 40 mM
HCl (pH 1.5) and then immediately diluted in buffer A (20% acetic acid,
100 mM NaCl, pH 1.6), including 0–20 mM TCEP at a protein concentra-
tion of 2 mg/mL (345 mM). The concentration of insulin was determined
using an extinction coefficient of 1.0 cm1 for 1 mg/mL at 276 nm (11).
Fibrillation was induced by heating the insulin solution at 70C for 13 h
without agitation. Samples of 2 mg/mL incubated insulin were dialyzed
by 20% acetate buffer and subsequently distilled water using a Slide-
A-Lyzer Mini dialysis unit (10,000 MWCO; Pierce) for removal of insulin
monomers and buffer exchange. For several experiments, insulin fibrils
and filaments were further concentrated by removal of supernatant after
centrifugation at 15,000 rpm for 30 min. No insulin sample was observed
in the supernatant. This centrifugation treatment did not alter the morphol-
ogies of the insulin fibrils or filaments (data not shown). The fibril concen-
trations and conversion ratio from insulin monomer into insulin fibrils were
determined beforehand by subtracting the insulin monomer concentration
measured in supernatants after centrifugation at 15,000 rpm for 60 min in
part of the incubated insulin samples.
ThT assay
For the time-course assay, 29 mL aliquots were taken at desired time inter-
vals from the incubated mixture and added to a 2 mL solution containing
5 mM ThT in 10 mM phosphate, pH 7.4, 150 mM NaCl (final pH of the
ThT solution decreased to 1.6), and fluorescence measurements were carried
out with a spectrofluorometer (FP-6500; Jasco, Tokyo, Japan) at 25C. The
excitation wavelength was 450 nm and the emission was measured at
485 nm. The intensities were corrected to correspond to the equal amount
(5 mM as monomer concentration) of the assembled insulin fibrils and fila-
ments after 13 h incubation.
To obtain fluorescence spectra, 10 mL of 1 mM insulin fibril/filament
samples dissolved in distilled water were added to a 2 mL solution contain-
ing 5 mM ThT in 10 mM phosphate, pH 7.4, and 150 mM NaCl, and
fluorescence spectra with the excitation wavelength at 450 nm at 25C
were obtained with the spectrofluorometer.
CR binding assay
To evaluate binding of CR to insulin fibrils and filaments, 10 mL of 1 mM
insulin fibril/filament samples dissolved in distilled water was added
to a 2 mL solution containing 25 mM CR in 10 mM phosphate, pH 7.4,
150 mM NaCl. After 30 min incubation at room temperature, absorbance
spectra were obtained with an ultraviolet-visible spectrophotometer
(CARY 50; Varian, Palo Alto, CA).
Far-ultraviolet circular dichroism
The far-ultraviolet (UV) circular dichroism (CD) spectra of 0.3 mg/mL
insulin fibrils and filaments were recorded using a Jasco-720W spectropo-
larimeter at 25C with a thermostated cell holder and a 2.0 mm-path-length
quartz cuvette. The CD spectrum of distilled water was subtracted from the
sample spectra for background correction.Biophysical Journal 96(8) 3331–3340Transmission electron microscopy
Transmission electron microscopy (TEM) measurements were performed
on a JEM-1011 transmission electron microscope (JEOL, Tokyo, Japan)
operated at 100 kV. Samples were diluted 10-fold with distilled water and
negatively stained with 2% (w/v) uranyl acetate solution on copper grids
(400-mesh) covered by carbon-coated Formvar film (JEOL DATUM,
Tokyo, Japan). The observation magnification was 25,000.
Fourier transform infrared spectroscopy
Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectra
were recorded on a FT/IR 615 spectrophotometer (Jasco, Tokyo, Japan) with
an MK II Golden Gate Single Reflection ATR system attachment (Specac,
Kent, UK) from 1750 to 1550 cm1 using a resolution of 4 cm1 and an
accumulation of 256 scans. Ten mL of the aliquots from the concentrated
(100 mg/mL) insulin fibril/filaments samples whose buffer was replaced
by D2O as described above were spread on the surface of a diamond crystal.
Curve-fitting of the amide I regions (raw spectra) was performed using Igor
Pro software (WaveMetrics, Portland, OR). Deconvolution analysis with
Gaussian function was carried out using the five peak positions that were
previously used for the analysis of protein amyloid: 1600–1615 cm1
(b-sheet, extended chain, side chain), 1615–1630 cm1 (b-sheet), 1630–1650
cm1 (a-helix), 1650–1690 cm1 (turn, disordered), and 1690–1700 cm1
(antiparallel b-sheet) (13,15,16). The bandwidth for each deconvoluted
spectra was set to 14 cm1 (halfwidth at half-maximum amplitude), except
for one for the 1690–1700 cm1 peak (4.5 cm1).
Micro-Raman spectroscopy
Raman spectra of solid samples were recorded using a Raman microscope
system (LabRAM; Dilor-Jobin Yvon, Horiba, Tokyo, Japan). In brief,
50–100 mL of the fibril solution dissolved in distilled water was directly applied
on a stainless-steel plate and subsequently air-dried. Solid samples were
observed through the microscope with a 100 object lens (Olympus, Tokyo,
Japan) and CCD camera (17). Approximately 10 mW of 514.5 nm laser
excitation from an Arþ laser was used to generate Raman scattering with
an acquisition time of 2–5 min. Spectra were normalized relative to the
1673 cm1 amide I band as an internal standard. Curve-fitting of the amide
I regions (raw spectra) was performed with the use of Igor Pro software
using peak positions that were previously used for analysis of proteins
(18). At least three individual spectra were obtained, and one is shown in
the figures. The bandwidth for each deconvoluted spectrum was set to 5,
25, 12, 9, and 12 cm1 for the 1618, 1630, 1660, 1675, and 1689 cm1
peak, respectively, except for one for the 1605 cm1 peak (7.3 cm1 for
fibrils and 17 cm1 for filaments, respectively).
Quantiﬁcation of S-S bonds in insulin ﬁbrils
Changes in the amount of S-S bonds in insulin fibrils were investigated by
analyzing the S-S stretching frequencies centered at 514 cm1 and S-H
stretching frequencies at 2574 cm1 of the Raman spectra (18). The peak
area was calculated by fitting with Gaussian functions using Levenberg-
Marquardt nonlinear least-squares methods in the Igor Pro software. The
amount of S-S bonds and free SH groups were estimated as peak area ratios
of each band to the amide I band (1673 cm1), respectively, as described in
a previous study (18).
Size exclusion chromatography of supernatants
Size exclusion chromatography was performed with a column
(G2000SWXL; Tosho, Tokyo, Japan) using a high-performance liquid
chromatography system (EZChromElite; Hitachi, Tokyo, Japan) connected
to a UV detector (L-2455; Hitachi). After incubation in buffer A in the pres-
ence or absence of 20 mM TCEP at a protein concentration of 2 mg/mL at
70C for 13 h, the samples were centrifuged (15,000 rpm for 60 min). The
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of TCEP. (A) Time-course assay monitored by ThT fluorescence: bovine
insulin was incubated in the absence () or presence (-) of 20 mM
TCEP. ThT fluorescence at 485 nm was measured. The intensities were cor-
rected to correspond to the equal amount (5 mM as monomer concentration)
of the assembled insulin fibrils and filaments after 13 h incubation. (B) ThTinsulin monomer concentration that remained in the supernatant was
determined as described. Then 100 mL aliquots of supernatant, including
0.2 mg/mL insulin sample diluted in the running buffer (45% acetonitrile
and 0.1% TFA), were loaded on the column at 25C. Elution was performed
with the running buffer at a flow rate of 1.0 mL/min and absorbance of the
sample was monitored at 220 nm.
Toxic assay
Cell viability was determined with the use of an MTT cell proliferation kit
(Roche, Basel, Switzerland), which is based on the conversion of tetrazolium
salt by mitochondrial dehydrogenase to a formazan product that is spectro-
photometrically measurable at 550 nm, according to the manufacturer’s
instructions.
PC12 cells (a clonal line of rat pheochromocytoma) were maintained in
RPMI1640 medium with 10% horse serum, 5% fetal bovine serum, peni-
cillin (100 U/mL), and streptomycin (100 mg/mL) in 5% CO2 at 37
C.
Cells were plated out in 96-well plates at a density of 50,000 cells/well
and grown overnight. The cells were then incubated in 100 mL medium in
the absence (control) and presence of insulin fibrils dialyzed with PBS buffer
instead of distilled water as described above. After 24 h of incubation, 10 mL
of MTT reagents were added to each well. The cells were incubated for 4 h at
37C in a 5% CO2 incubator. The reaction was stopped by adding 100 mL of
10% SDS in 10 mM HCl. The plates were read with a microplate reader
(SPECTRAmax; Molecular Devices, Sunnyvale, CA) at 550 nm. Each
data point was an average of three triplet-well assays.
RESULTS
Fibrillation of insulin in the presence of TCEP
The time course of the fibrillation of bovine insulin with
and without the reducing agent, TCEP, was monitored by
ThT fluorescence (Fig. 1 A). TCEP was used because it is
known to work under acidic conditions (14), which are
classic and widely employed in insulin fibrillation studies
(8,11). ThT is a widely used fluorescence dye whose fluores-
cence emission increases upon binding to stacked b-sheet
structures in amyloid fibrils (5,19). In the absence of
TCEP, insulin fibrillation was observed after a lag time of
~3 h, as previously shown (8,11). TEM observations
confirmed the formation of straight fibrils (Fig. 2 A), as
reported in previous studies (8,11,12). The conversion ratio
from insulin monomer into insulin fibrils after 13 h incuba-
tion was calculated to be 97.5% by measuring the amount
of unconverted insulin monomer that remained in the super-
natants after centrifugation of part of the incubated insulin
samples.
assay: 10 mL of 1 mM insulin aggregates formed in the absence (broken line)
and presence (solid line) of 20 mM TCEP dissolved in distilled water were
added to a 2 mL solution containing 5 mM ThT in 10 mM phosphate, pH 7.4,
150 mM NaCl (dotted line), and fluorescence spectra with the excitation
wavelength at 450 nm at 25C were obtained by the spectrofluorometer.
(C) CR assay: 10 mL of 1 mM insulin aggregates formed in the absence
(broken line) and presence (solid line) of 20 mM TCEP dissolved in distilled
water were added to a 2 mL solution containing 25 mM CR in 10 mM phos-
phate, pH 7.4, 150 mM NaCl (dotted line). After 30 min incubation at room
temperature, absorbance spectra were obtained with an ultraviolet-visible
spectrophotometer.Biophysical Journal 96(8) 3331–3340
3334 Zako et al.FIGURE 2 TEM analysis of insulin aggregates. Bovine
insulin was incubated at a final concentration of 2 mg/mL
at pH 1.6 and 70C for 13 h in the absence (A) and presence
(B) of 20 mM TCEP. Equal molar amounts of insulin
A-chain and B-chain were co-incubated under identical
conditions in the absence (C) and presence (D) of 20 mM
TCEP. The scale bar represents 200 nm.In contrast, when insulin was incubated with excess
TCEP, only a small increase in the ThT fluorescence signal
was observed (Fig. 1 A). Since almost the same ThT intensi-
ties were observed for insulin samples incubated with 1, 5, or
20 mM TCEP (data not shown), samples incubated with
20 mM TCEP were used for further studies. TEM imaging
revealed that filamentous insulin amyloids, which differ
from intact fibrils, were formed in the presence of TCEP
(Fig. 2 B). TCEP-treated insulin filaments were more highly
flexible than intact insulin fibrils. It should be noted that
a mixture of the individual insulin A- and B-chains did not
form this filamentous amyloid structure, regardless of the
presence of TCEP (Fig. 2, C and D). These results indicate
that insulin filaments were formed only when intact insulin
was incubated in the presence of TCEP, as discussed later.
The conversion ratio from insulin monomer into insulin fila-
ments after 13 h incubation was calculated to be 69.5%.
Of interest, small but significant ThT fluorescence was
observed for the insulin filaments when the dissolved buffers
were exchanged to distilled water before the assay, which
indicates that ThT can bind to insulin filaments weakly at
pH 7.4 (Fig. 1 B). Since only a trace ThT intensity was
observed for insulin filaments at pH 1.6 (Fig. 1 A), this result
suggests that insulin filaments are more pH-sensitive in ThT
binding than insulin fibrils.
A CR binding assay was also carried out. CR is also
widely used to detect amyloid formation (5). The buffers
of both insulin fibrils and filaments were also exchanged to
distilled water before the assay. As shown in Fig. 1 C, no
change in the absorbance spectra was observed upon addi-
tion of filamentous insulin amyloids, although the same
amount of insulin fibrils induced a significant spectralBiophysical Journal 96(8) 3331–3340change. These results indicate that CR does not bind to
insulin filaments formed in the presence of TCEP, whereas
ThT can weakly bind to insulin filaments.
Secondary structure of insulin ﬁbrils
and ﬁlaments
The far-UV CD spectra of insulin fibrils and filaments are
shown in Fig. 3. The spectrum of native insulin before incu-
bation is also shown for comparison. The spectrum had
double minima at 208 and 222 nm, which is characteristic
of the a-helical structure. In contrast, both fibrils and fila-
ments showed a b-sheet structure, with a single minimum
observed at ~220 nm. The peak of filaments differed a little
from that of fibrils. These longer-wavelength peaks have
been observed in various kinds of fibrils and are thought to
be evidence of the formation of b-sheet structures (9,20).
ATR-FTIR was used to study the secondary structures of
insulin fibrils and filaments. Previous studies showed that
monomeric native insulin is characterized by a peak at
~1654 cm1, which is characteristic of a-helical proteins,
and when converted into fibrils the peak shifts to ~1628 cm1,
which is consistent with the high b-sheet structure content of
the fibrils (15,21,22). In our experiment, a similar peak shift
was also observed between the ATR-FTIR spectra of native
insulin and insulin fibrils (Fig. 4, A and B). Although the
second derivatives of IR spectra are usually used to identify
the peaks of each component band, the resolutions of our
spectra were not sufficient for the analysis. Therefore, our
spectra were analyzed using five bands having a center within
1600–1615, 1615–1640, 1640–1660, 1660–1690, and 1690–
1700 cm1, which are assigned to extended chain b-sheet or
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allel b-sheet structure, respectively (see also Table S1 in the
Supporting Material). As a result, it was revealed that the rela-
tive area of the band corresponding to the a-helix (at 1642–
1644 cm1) decreased to only 17% in insulin fibrils, whereas
the b-sheet bands (1623 cm1) were significantly elevated to
62%. This observation indicates that the formation of the fibril
is accompanied by the conversion of the a-helix to b-sheet
structures. The peak position of the b-sheet band in insulin
fibrils (1623 cm1) is significantly different from that in
native insulin (1628 cm1), which is typical for amyloid
fibrils, suggesting intermolecular b-sheet formation (23).
The insulin filaments gave the spectrum shown in Fig. 4 C,
which has a strong band at 1619 cm1 and an additional band
at 1693 cm1. The deconvoluted spectra show 1600, 1619,
1644, 1668, and 1693 cm1 bands. The large intermolecular
b-sheet band at 1619 cm1 was also observed for insulin
filaments. In comparison with those of the insulin fibrils,
the 1644 cm1 band assigned to a-helix remarkably
increased, and the bands around 1600 and 1668 cm1 were
reduced. The 1668 cm1 band can be assigned to nonhydro-
gen-bonded amide groups in a turn/disordered structure (24).
Because a-helix structure is formed by the hydrogen bonds
FIGURE 3 Far-UV CD spectra of insulin samples: 0.3 mg/mL insulin
samples of native insulin (dotted line), insulin fibrils formed in the absence
of TCEP (broken line), and insulin filaments formed in the presence of
20 mM TCEP (solid line) were assayed. The photomultiplier voltage is
also shown in the figure.between amide groups in the same strand, the increase in
the a-helical contents indicates an increase in the intramolec-
ular interactions. Moreover, the decrease in the band at
1600 cm1 suggests a decrease in the intermolecular hydro-
gen bonds in an extended b-sheet. Therefore, it is plausible
that insulin filaments harbor more intramolecular interac-
tions than insulin fibrils.
The secondary structures of insulin fibrils and filaments
were also investigated by means of Micro-Raman
FIGURE 4 Changes in the secondary structure composition of insulin
samples with FTIR. ATR-FTIR spectra insulin samples: (A) native insulin,
(B) insulin fibrils formed in the absence of TCEP, and (C) insulin filaments
formed in the presence of 20 mM TCEP. The dotted line represents the raw
data, and the solid line represents the fitted data used for deconvolution
(broken line).Biophysical Journal 96(8) 3331–3340
3336 Zako et al.FIGURE 5 Raman studies of insulin
fibrils and filaments. (A) Solid-state
spectra of insulin fibrils and filaments
formed in the absence and presence of
20 mM TCEP. Spectra were normalized
relative to the 1673 cm1 amide I band
as an internal standard. 1) A-chain and
B-chain incubated with TCEP. 2)
A-chain and B-chain incubated without
TCEP. 3) Insulin incubated with TCEP.
4) Insulin incubated without TCEP.
Peak frequencies are indicated in the
figure. The broken lines indicate S-S
stretching frequencies centered at
514 cm1 and S-H stretching frequen-
cies at 2574 cm1, respectively. (B
and C) Expansion of the amide I Raman
region with Gaussian deconvolution of
insulin fibrils formed in the absence of
TCEP (B) and filaments formed in the
presence of TCEP (C). (D) Expansion
of the amide III Raman region of insulin
fibrils formed in the absence of TCEP
(broken line) and insulin filaments in
the presence of TCEP (solid line).spectroscopy (Fig. 5). Fig. 5, B and C, show an expansion of
the amide I region of the Raman spectra of insulin fibrils and
filaments, respectively. In the amide I region, two spectra
gave rise to a peak around 1675 cm1, assigned to a b-sheet
structure, although the peak at ~1650–1700 cm1 of the fila-
ment spectrum was broader than the corresponding part of
the fibril spectrum. A component analysis was conducted
according to a previous report (17), and the results are given
in Table S2. In fibrils, the major contribution (55%) was from
organized b-sheet structures, along with helix (15%) and
loose b-strand/disordered (30%) structures (Fig. 5 B). In fila-
ments, the contribution from organized b-sheet structures
(40%) was lower, and the helical content (22%) was signif-
icantly higher (Fig. 5 C). These results are consistent with
those obtained by IR spectral analysis.
Of interest, in the ATR-FTIR spectra, a 1693 cm1 peak
was observed only for insulin filaments (Fig. 4 C), which
suggests that the secondary structure of insulin filaments
differs from that of insulin fibrils. Since this peak is assigned
to an antiparallel b-sheet structure (15,21,22,25), these
spectra suggest that insulin filaments induced by TCEP
have an antiparallel b-sheet structure, whereas fibrils have
a parallel b-sheet structure.
The antiparallel b-sheet structure of insulin filaments was
also supported by Raman spectra (Fig. 5 D). The Raman
intensity of the amide III region was stronger in insulin fila-
ments than in insulin fibrils, which supports the antiparallel
b-sheet structure.
Quantiﬁcation of S-S bonds in insulin ﬁbrils
Changes in the amount of S-S bonds in insulin fibrils were
investigated by analyzing the S-S stretching frequenciesBiophysical Journal 96(8) 3331–3340centered at 514 cm1 and the S-H stretching frequencies at
2574 cm1 of the Raman spectra as previously described.
As shown in Fig. 5 A, the peak area at 514 cm1 decreased
and the peak area at 2574 cm1 increased upon addition of
TCEP, strongly supporting the premise that TCEP actually
reduced the disulfide bonds of insulin. The amounts of S-S
bonds were estimated as peak area ratios of each band to
the amide I band (1673 cm1), respectively (18). The
remaining S-S bonds in insulin filaments were roughly esti-
mated to be 27%, 15%, and 13% for insulin incubated with 1,
5, or 20 mM TCEP, respectively, assuming that 100% S-S
bond remained for insulin fibrils made without TCEP,
and that 0% S-S bonds are present in fibrils made by insulin
A- and B-chains (data not shown for Raman spectra of
insulin filaments incubated with 1 and 5 mM TCEP). This
result indicates that S-S bonds partially remained for insulin
filaments.
Size exclusion chromatography of supernatants
To further confirm that the A- and B-chains of an insulin mole-
cule treated with TCEP remained associated, gel filtration
analysis of supernatants after centrifugation (15,000 rpm for
60 min) of an insulin sample incubated at 70C for 13 h was
carried out. As shown in Fig. 6, there was no separated B-chain
in the supernatant of incubated insulin with TCEP, which indi-
rectly supports the idea that the A- and B-chains of the insulin
molecule treated with TCEP remained associated.
Toxic assay
The cell toxicity of insulin fibrils and filaments in the
PC12 pheochromocytoma cell line was examined with
MTT assay (Fig. 7). Insulin fibrils showed dose-dependent
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showed no detectable cell toxicity at the examined concen-
trations. To exclude the possibility of structural changes in
insulin fibrils and/or filaments resulting from the incubation
process (24 h in cell culture medium) in the toxicity assay,
the persistence of both structures after incubation was
confirmed by TEM observation and ThT assay (data not
shown). These results imply that the morphology of insulin
amyloid fibrils is correlated with their cell toxicity.
DISCUSSION
Insulin is composed of disulfide-linked peptides (A- and
B-chains) and provides a model for nonneuropathic systemic
amyloidoses and human diseases associated with amyloids
(3,8). In such pathological processes, proteins lose their
native structures and form fibrils. It has been proposed that
bovine insulin fibrillation occurs though the dissociation of
native oligomers into monomers, and that the monomers
undergo a structural change to a partially folded intermediate
FIGURE 6 Size exclusion chromatography of supernatants of incubated
insulin. After incubation of insulin in buffer A in the presence and absence
of 20 mM TCEP at a protein insulin concentration of 2 mg/mL at 70C for
13 h, the samples were centrifuged (15,000 rpm for 60 min). The 100 mL
aliquots of supernatant, including 0.2 mg/mL insulin samples treated with
TCEP (solid line) and without TCEP (broken line) diluted in the running
buffer (45% acetonitrile and 0.1% TFA), were applied to a G2000SWXL
high-performance liquid chromatography column at 25C at a flow rate of
1.0 mL/min, and the absorbance of the sample was monitored at 220 nm.
The 100 mL aliquots of buffer A diluted (1/5 dilution) in the running buffer
were applied as a control (dotted line). Native insulin (5734 kDa) and insulin
B-chain (3399 kDa) were used for marker samples.that has a strong propensity for fibrillation. Thus, fibrillation
of bovine insulin occurs readily at acidic pH (a condition
favoring monomerization) (8,11).
The roles of the A- and B-chains have been investigated,
and it was shown that a region in the B-chain is important for
bovine insulin fibril formation (10). It was also demonstrated
that the B-chain of bovine insulin forms straight fibrils under
acidic conditions (12,13). The A-chain of bovine insulin was
shown to form fibrils that differ from those of the B-chain
fibrils and intact insulin fibrils in terms of diameter, helical
repeat, and twist properties (12).
Although it is rarely observed in vivo, fibrillation of
insulin has long complicated its manufacture and use in the
treatment of diabetes mellitus. We chose to investigate the
molecular basis of insulin fibrillation as a model for an
important class of amyloidogenic proteins and in relation
to cell toxicity. In this study, we demonstrated that bovine
insulin forms flexible filaments in the presence of TCEP,
which works as a reducing agent in acidic conditions. We
investigated the structural characteristics and cell toxicity
of these novel bovine insulin filaments and compared them
with those of intact insulin fibrils.
Secondary structure
Proteins undergo cross-b assembly to form fibrils (4).
Although they may have similar morphologies at EM resolu-
tion, polypeptides can exhibit different structural modes of
cross-b assembly, differing in protofilament orientation
(parallel or antiparallel), registry, and packing (27). In this
study, we found that in the presence of TCEP, bovine insulin
formed flexible filaments that were very different from intact
insulin fibrils, as shown in Fig. 2. The far-UV CD spectra of
these fibrils and filaments indicate the formation of typical
FIGURE 7 Cell toxicity of insulin fibrils and filaments. Cell viability was
determined with the use of an MTT cell proliferation kit. PC12 cells were
plated in 96-well plates at a density of 50,000 cells/well and grown over-
night. Cells were then incubated in the absence (control) and presence of
either insulin filaments (black) or insulin fibrils (white) dialyzed with PBS
buffer at indicated concentrations.Biophysical Journal 96(8) 3331–3340
3338 Zako et al.b-structures (Fig. 3). It should be noted that the peak wave-
length of insulin filaments (222 nm) was slightly different
from that of insulin fibrils (225 nm). Although far-UV CD
spectra have been used to detect b-structures of various
amyloids (3,9,20,28), the peak positions differ depending
on their parent proteins, which has not been discussed to
date. However, our study suggests that CD spectra could
reflect the morphological difference of amyloid fibrils and
filaments from the same parent protein. Different binding
properties of ThT and CR dyes on fibrils and filaments
(Fig. 1) would also support the idea that insulin fibrils
and filaments may differ in the stacking arrangement of
b-strands, since these dyes were thought to bind specifically
to the b-sheet arranged perpendicularly to the long axis of the
fibrils (19). Most recently, luminescent conjugated polymers
(LCPs) were introduced for the study of amyloid structures
(29). It should be noted that LCPs were able distinguish
different types of amyloid fibrils of Ab in vitro and
in vivo. Stabo-Eeg et al. (30) also reported that it is possible
to distinguish conformational differences between amyloid
fibrils formed from nonreduced and reduced insulin with
separated A- and B-chains using an LCP. Thus, it would
be interesting to examine the structural differences of insulin
fibrils and filaments using these probes.
Further detailed analysis was carried out with the use of
ATR-FTIR. FTIR spectroscopy has already been applied to
elucidate amyloid fibril structure (21,23). Our results for
ATR-FTIR spectra (Fig. 4) and secondary structure contents
(summarized in Table S1) of insulin fibrils and filaments
support the a-to-b conversion from native insulin, which is
consistent with the results of CD spectra (Fig. 3) and
micro-Raman spectroscopy (Fig. 5, B and C, and Table
S2). It is notable that filaments exhibit a significantly lower
content of organized b-sheet and a higher content of loose
b-strand/disordered structure than fibrils (Table S2), which
may be related to the formation of flexible insulin filaments.
Although insulin fibrils and filaments showed similarly
high b-structure contents, a difference at ~1695 cm1 was
evident (Fig. 4, B and C). A similar peak was observed
for the aggregation of bovine insulin catalyzed by protein
disulfide isomerase (31). Since this peak is assigned to the
antiparallel b-sheet structure (15,21,22,25), this result
suggests that bovine insulin can exhibit different orientation
modes of cross-b assembly, i.e., an antiparallel b-sheet
structure for insulin filaments induced by TCEP and a
parallel b-sheet structure for insulin fibrils. This idea is sup-
ported by the results of structural studies of other amyloid
fibrils, in which both FTIR and structural analyses were
carried out. For example, Ab34–42 and Ab16–22 were shown
to form antiparallel b-sheet structures by solid-state NMR
(32,33) and to have an obvious 1695 cm1 peak in FTIR
spectra (34,35). On the other hand, Ab10–35 and Ab1–42,
which form parallel b-sheet structures (36,37), showed
a very weak peak, if any, at 1695 cm1 in FTIR spectra
(38,39). In a simulation study, it was found that a more stableBiophysical Journal 96(8) 3331–3340antiparallel b-sheet structure could be expected when a clear
band was observed at 1695 cm1 (25). Together, the results
of these studies strongly support our idea concerning bovine
insulin.
The antiparallel b-sheet structure of insulin filaments can
be confirmed with micro-Raman spectroscopy. As shown
in Fig. 5, C and D, distinct amide I and III bands appeared
at 1675 and 1240 cm1, respectively, for insulin filaments
formed in the presence of TCEP, which also supports the
antiparallel b-sheet configuration (18,40).
Quantiﬁcation of S-S bonds
To confirm the reduction of S-S bonds in insulin filaments by
TCEP, the amounts of S-S bonds in insulin fibrils and fila-
ments were examined by means of micro-Raman spectros-
copy. Raman spectroscopy has been used to analyze S-S
bonds of biological samples (18). As shown in Fig. 5 A, it
was obvious that some S-S bonds remained in the insulin
filaments formed in the presence of TCEP when compared
with the data of insulin fibrils from a mixture of insulin
A- and B-chains; ~13% of the S-S bonds remained in insulin
filaments formed in the presence of TCEP, even in the pres-
ence of excess TCEP.
The mixture of insulin A- and B-chains did not form
filaments even in the presence of TCEP, but it did form fibrils
similar to intact insulin fibrils (Fig. 2, C and D). The gel
filtration chromatography analysis of supernatants after
centrifugation of incubated insulin samples showed that the
A- and B-chains of an insulin molecule treated with TCEP
remained associated (Fig. 6). These results suggest that
partial reduction of S-S bonds in bovine insulin induced
formation of filaments. It is plausible that decreases in
structural constraints for insulin molecules by partial reduc-
tion of S-S bonds might induce formation of a more flexible
filamentous structure. This agrees well with previous studies
of b2-microglobulins, which could not form typical amyloid
fibrils when the disulfide bond was reduced, and instead
formed immature protofibrils, indicating that the disulfide
bond is important for amyloid fibril formation (28,41).
However, further experiments, including mutagenesis
studies of cysteine residues, will be needed to determine
which disulfide bond(s) are responsible for the observed
morphological differences between insulin fibrils and
filaments. In a study by Mishra et al. (42), it was shown
that nicked lysozyme by partial acid hydrolysis formed
spherical oligomeric structures as fibrillation intermediate
states that did not appear in the intact lysozyme fibrillation
process. This result also supports the idea that partial
cleavage of a protein could have a dramatic effect on its
amyloid formation.
Low cell toxicity of insulin ﬁlaments
Fibrils made from proteins, such as Ab, are known to be cyto-
toxic and cause various diseases (2,3). Of interest, insulin
Novel Insulin Filaments 3339filaments showed no cell toxicity at the examined concentra-
tions, whereas significant cell toxicity was observed for
insulin fibrils at the same concentrations (Fig. 7).
Since our results indicate that morphologically different
protein aggregations from the same parent protein exhibit
different cell toxicities, it can be suggested that the
morphology of protein fibrils is critical to the causation of
cell death by amyloid fibrils. This idea is consistent with
the recent notion that soluble oligomers, which usually are
in an intermediate state before forming amyloid fibrils, are
more toxic than fibrils (43). Various proteins, such as Ab,
a-synuclein, transthyretin, and nondisease-associated
proteins, have been shown to form similar toxic oligomers
(26,43,44). It is plausible that flexible insulin filaments do
not damage the cell membrane, and therefore have only
low toxicity. This idea is consistent with recent observations
by Gharibyan et al. (45) that amyloid fibrils of hen lysozyme
induce membrane damage leading to cell death. In addition,
it has been reported that amyloid fibrils bind to several
surface receptors, which is suggested to contribute cellular
stress and toxicity (46). Thus it is also plausible that insulin
filaments are not toxic, since they are not recognized by such
surface receptors. Although these two possible reasons are
not mutually exclusive, further studies are necessary to eluci-
date the low toxicity of insulin filaments.
SUMMARY AND CONCLUSIONS
In this study, we demonstrated that bovine insulin formed
flexible filaments in the presence of TCEP. The insulin
filaments, possibly formed due to partial reduction of S-S
bonds in the insulin molecules, differ from the intact insulin
fibrils in terms of their secondary structures. The insulin fila-
ments were assigned to an antiparallel b-sheet structure,
whereas the intact insulin fibrils had a parallel b-sheet struc-
ture. However, further studies are necessary to clarify their
structural differences in detail. The distinct difference in
cell toxicities supports the idea that the morphology of
amyloid fibrils is correlated with their cellular toxicity. A
detailed comparison between toxic fibril structures and
nontoxic filamentous structures should shed new light on
the mechanisms behind amyloid-associated diseases and
possible pharmacological approaches to the various diseases
caused by amyloid fibrils.
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